These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

760 related articles for article (PubMed ID: 19286222)

  • 1. Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease.
    Featherstone JM; Fernando HS; Theaker JM; Simmonds PD; Hayes MC; Mead GM
    J Urol; 2009 May; 181(5):2090-6; discussion 2096. PubMed ID: 19286222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
    Mosharafa AA; Foster RS; Bihrle R; Koch MO; Ulbright TM; Einhorn LH; Donohue JP
    Cancer; 2003 Aug; 98(4):753-7. PubMed ID: 12910519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
    Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
    J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Outcomes Following Surgical Management of Clinical Stage II Sex Cord Stromal Tumors.
    Calaway AC; Tachibana I; Masterson TA; Foster RS; Einhorn LH; Cary C
    Urology; 2019 May; 127():74-79. PubMed ID: 30807775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment of testicular sex cord-stromal tumors: critical review.
    Acar C; Gurocak S; Sozen S
    Urology; 2009 Jun; 73(6):1165-71. PubMed ID: 19362328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
    Cooper DE; L'esperance JO; Christman MS; Auge BK
    J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome in testicular sex cord stromal tumors: testis sparing vs. radical orchiectomy and management of advanced disease.
    Nicolai N; Necchi A; Raggi D; Biasoni D; Catanzaro M; Piva L; Stagni S; Maffezzini M; Torelli T; Faré E; Giannatempo P; Pizzocaro G; Colecchia M; Salvioni R
    Urology; 2015 Feb; 85(2):402-6. PubMed ID: 25623702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up.
    Hölscher G; Anthuber C; Bastert G; Burges A; Mayr D; Oberlechner E; Schubert-Fritschle G; Sinz S; Sommer H; Schmalfeldt B; Engel J;
    Acta Obstet Gynecol Scand; 2009; 88(4):440-8. PubMed ID: 19191075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcome of testicular seminoma in 294 patients].
    Song Y; Yang L; Ma JH; Liu XF; Wang JW
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):626-9. PubMed ID: 19102945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance.
    Warde P; Gospodarowicz MK; Banerjee D; Panzarella T; Sugar L; Catton CN; Sturgeon JF; Moore M; Jewett MA
    J Urol; 1997 May; 157(5):1705-9; discussion 1709-10. PubMed ID: 9112510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.
    Spiess PE; Brown GA; Liu P; Tannir NM; Tu SM; Evans JG; Czerniak B; Kamat AM; Pisters LL
    Cancer; 2006 Oct; 107(7):1483-90. PubMed ID: 16944541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
    Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
    Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
    Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.
    Sánchez-Ortiz R; Huang SF; Tamboli P; Prieto VG; Hester G; Pettaway CA
    J Urol; 2005 Jun; 173(6):1958-65. PubMed ID: 15879790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.